About us
NSRI has extensive expertise in the detection and identification of chemical and biological agents; furthermore, NSRI/NU is internationally known for its focus on developing clinical methodologies to detect exposure to bioagents and nerve-agents. The objectives of NSRI’s research in this areas are to develop methods and tools that can detect both known and unknown threats that are accurate, field-deployable, provide rapid results, detect bioactive levels, and require minimal training to use. Our nation’s ability to detect and identify the deliberate use or natural emergence of pathogens depends on our technological capabilities. NSRI is actively pursuing the development of tools and methods to advance and integrate technologies enabling early detection, identification, and situational awareness of existing or potential threats. Unique to NSRI is: • Development of autonomous and adaptive sensing – from the development of theoretical platforms to optimizing matured assays. • Partnership with government agencies to advance molecular assays with existing DoD technologies. • Repositories of select agents and capable facilities to both characterize these agents and evaluate therapies. • Synergistic relationship with the nationally recognized Nebraska Public Health Lab known for chemical and biological agent detection, assay development and training. • Expertise in genomics, transcriptomics, proteomics, metabolomics and bioinformatics
- Website
-
https://nsri.nebraska.edu/researchcapabilities/detection-of-chemical-and-biological-weapons
External link for Detection of Chemical and Biological Weapons
- Industry
- Research
- Company size
- 11-50 employees
- Headquarters
- Omaha, NE
- Founded
- 2012